Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis

被引:195
作者
Curtin, JJ [1 ]
Donlan, RM [1 ]
机构
[1] Ctr Dis Control & Prevent, NCID, DHQP, ELB,EAMS, Atlanta, GA 30333 USA
关键词
D O I
10.1128/AAC.50.4.1268-1275.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Use of indwelling catheters is often compromised as a result of biofilm formation. This study investigated if hydrogel-coated catheters pretreated with a coagulase-negative bacteriophage would reduce Staphylococcus epidermidis biofilm formation. Biofilms were developed on hydrogel-coated silicone catheters installed in a modified drip flow reactor. Catheter segments were pretreated with the lytic S. epidermidis bacteriophage 456 by exposing the catheter lumen to a 10-log-PFU/ml culture of the bacteriophage for 1 h at 37 degrees C prior to biofilm formation. The untreated mean biotilm cell count was 7.01 +/- 0.47 log CFU/cm(2) of catheter. Bacteriophage treatment with and without supplemental divalent cations resulted in log-CFU/cm(2) reductions of 4.47 (P < 0.0001) and 2.34 (P = 0.001), respectively. Divalent cation supplementation without bacteriophage treatment provided a 0.67-log-CFU/cm(2) reduction (P = 0.053). Treatment of hydrogel-coated silicone catheters with an S. epidermidis bacteriophage in an in vitro model system significantly reduced viable biofilm formation by S. epidermidis over a 24-h exposure period, suggesting the potential of bacteriophage for mitigating biofilm formation on indwelling catheters and reducing the incidence of catheter-related infections.
引用
收藏
页码:1268 / 1275
页数:8
相关论文
共 70 条
[1]  
Adams M. H., 1959, BACTERIOPHAGES
[2]  
[Anonymous], 1998, HOSP INFECT
[3]   Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves [J].
Barrow, P ;
Lovell, M ;
Berchieri, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (03) :294-298
[4]   INTRALUMINAL ANTIBIOTIC-TREATMENT OF CENTRAL VENOUS CATHETER INFECTIONS IN PATIENTS RECEIVING PARENTERAL-NUTRITION AT HOME [J].
BENOIT, JL ;
CARANDANG, G ;
SITRIN, M ;
ARNOW, PM .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) :1286-1288
[5]   Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium [J].
Biswas, B ;
Adhya, S ;
Washart, P ;
Paul, B ;
Trostel, AN ;
Powell, B ;
Carlton, R ;
Merril, CR .
INFECTION AND IMMUNITY, 2002, 70 (01) :204-210
[6]  
CAPDEVILA JA, 1996, ANTIMICROBICS INFECT, V15, P9
[7]  
CARBALLO J, 1991, REV ESP FISIOL, V47, P201
[8]   The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms [J].
Ceri, H ;
Olson, ME ;
Stremick, C ;
Read, RR ;
Morck, D ;
Buret, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1771-1776
[9]  
CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
[10]  
CISLO M, 1987, ARCH IMMUNOL THER EX, V35, P175